Dear Sirs, Congenital myasthenic syndromes (CMS) are rare genetic diseases of the neuromuscular junction with 18 causative genes identified to date [1] . Among many patients investigated worldwide, MUSK mutations were identified in only nine patients [2] [3] [4] [5] . Here, we describe clinical, neurophysiological and molecular features of two Italian siblings who carry compound heterozygous mutations in MUSK, one of which is novel.
The first sibling is a 27-year-old woman. At birth, she had laryngeal stridor and respiratory failure requiring mechanical ventilation and tube feeding during the first month of life. She had recurring respiratory failure at age 3 months and frequent pulmonary infections during infancy. Her subsequent clinical course was characterized by bilateral fluctuating eyelid ptosis, ophthalmoparesis, mild dysphagia and exertional dyspnoea, severe upper and lower limb weakness. Menstrual periods and fever worsened her bulbar symptoms and fatigability.
At age 8 years, a right deltoid muscle biopsy done elsewhere showed muscle fiber atrophy and type I fiber predominance. At age 13 years, a biopsy of left biceps brachii was interpreted as normal. At age 18 years, 3-Hz repetitive stimulation of the axillary nerve elicited a 37 % decrement and needle EMG revealed a diffuse myopathic pattern. She was treated with 240 mg/day pyridostigmine but this soon had to be discontinued due to rapidly worsening symptoms and severe side effects. At age 26 years, she was readmitted with a waddling gait, bilateral eyelid ptosis, oculoparesis on horizontal and vertical gaze, double vision on extreme lateral gaze, mild tongue weakness and atrophy, mild nasal speech, severe orbicularis oculi and oris weakness, severe proximal and neck flexors muscle The second sibling is a 29-year-old man. He had bilateral fluctuating eyelid ptosis since birth and later developed minimal fatigable leg weakness on running that did not limit his daily and sport activities. Examination at age 28 years demonstrated only mild tongue weakness and atrophy, mild bilateral eyelid ptosis, limitation of horizontal and vertical gaze without diplopia, mild facial and minimal biceps femoris weakness. Three-Hz repetitive stimulation of the accessory nerve elicited a 20 % decremental response; needle EMG examination showed mild myopathic changes. He has never taken pyridostigmine.
Direct sequencing of all MUSK exons and their flanking intronic regions in both siblings revealed a previously identified c.2368G[A (p.Val790Met) mutation in exon 15 and a novel c.467delA mutation in exon 4, resulting in frame-shift and premature termination of translation (p.Lys156Argfs*20) [2] . The parents are not consanguineous and each carries one of the two mutations (Fig. 1) .
Few patients with MUSK-CMS have been reported so far (see Table 1 for clinical and molecular features). Eyelid ptosis and/or respiratory problems at birth or early life are common features of MUSK-CMS and all patients had also oculoparesis [2] [3] [4] [5] . Hence, the association of early eyelid ptosis and respiratory muscle weakness in a CMS patient points to MUSK as one of the candidate genes. Pyridostigmine is usually ineffective or only slightly beneficial and worsened the symptoms in our female patient [2] [3] [4] [5] .
Interestingly, most identified mutations in MUSK are missense and positioned in exons 14-15, corresponding to the kinase domain of the MuSK protein. In our patients, one mutation was located in exon 15 and the other in exon 4 [2] [3] [4] [5] . In our kinship, the sister is much more severely affected than the brother. A gender-effect might be hypothesized since menstrual periods and fever worsened her symptoms. Although intrafamily phenotypic variability in MUSK-CMS has been already reported, in our opinion clinical variability in our patients is very impressive [3] .
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